Literature DB >> 33489098

Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable.

Radha K Dhiman1,2,3,4, Madhumita Premkumar1.   

Abstract

Entities:  

Year:  2021        PMID： 33489098      PMCID： PMC7805299          DOI： 10.1002/cld.978

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  20 in total

1.  Outcomes of treatment for hepatitis C virus infection by primary care providers.

Authors:  Sanjeev Arora; Karla Thornton; Glen Murata; Paulina Deming; Summers Kalishman; Denise Dion; Brooke Parish; Thomas Burke; Wesley Pak; Jeffrey Dunkelberg; Martin Kistin; John Brown; Steven Jenkusky; Miriam Komaromy; Clifford Qualls
Journal:  N Engl J Med       Date:  2011-06-01       Impact factor: 91.245

2.  Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.

Authors:  Jason Grebely; Olav Dalgard; Brian Conway; Evan B Cunningham; Philip Bruggmann; Behzad Hajarizadeh; Janaki Amin; Julie Bruneau; Margaret Hellard; Alain H Litwin; Philippa Marks; Sophie Quiene; Sharmila Siriragavan; Tanya L Applegate; Tracy Swan; Jude Byrne; Melanie Lacalamita; Adrian Dunlop; Gail V Matthews; Jeff Powis; David Shaw; Maria Christine Thurnheer; Martin Weltman; Ian Kronborg; Curtis Cooper; Jordan J Feld; Chris Fraser; John F Dillon; Phillip Read; Ed Gane; Gregory J Dore
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-01-06

3.  Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective.

Authors:  Radha K Dhiman; Gagandeep S Grover; Madhumita Premkumar; Sunil Taneja; Ajay Duseja; Sahaj Rathi; Sandeep Satsangi
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-01       Impact factor: 2.839

4.  Real-world outcomes of unrestricted direct-acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience.

Authors:  J Haridy; A Wigg; K Muller; J Ramachandran; E Tilley; V Waddell; D Gordon; D Shaw; D Huynh; J Stewart; R Nelson; M Warner; M Boyd; M A Chinnaratha; D Harding; L Ralton; A Colman; D Liew; G Iyngkaran; E Tse
Journal:  J Viral Hepat       Date:  2018-07-10       Impact factor: 3.728

5.  Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting.

Authors:  Radha K Dhiman; Gagandeep S Grover; Madhumita Premkumar; Sunil Taneja; Ajay Duseja; Sanjeev Arora; Sahaj Rathi; Sandeep Satsangi; Akash Roy
Journal:  J Hepatol       Date:  2019-07-17       Impact factor: 25.083

6.  The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.

Authors:  Jeffrey D Stanaway; Abraham D Flaxman; Mohsen Naghavi; Christina Fitzmaurice; Theo Vos; Ibrahim Abubakar; Laith J Abu-Raddad; Reza Assadi; Neeraj Bhala; Benjamin Cowie; Mohammad H Forouzanfour; Justina Groeger; Khayriyyah Mohd Hanafiah; Kathryn H Jacobsen; Spencer L James; Jennifer MacLachlan; Reza Malekzadeh; Natasha K Martin; Ali A Mokdad; Ali H Mokdad; Christopher J L Murray; Dietrich Plass; Saleem Rana; David B Rein; Jan Hendrik Richardus; Juan Sanabria; Mete Saylan; Saeid Shahraz; Samuel So; Vasiliy V Vlassov; Elisabete Weiderpass; Steven T Wiersma; Mustafa Younis; Chuanhua Yu; Maysaa El Sayed Zaki; Graham S Cooke
Journal:  Lancet       Date:  2016-07-07       Impact factor: 79.321

Review 7.  The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis.

Authors:  Baligh R Yehia; Asher J Schranz; Craig A Umscheid; Vincent Lo Re
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

8.  Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey.

Authors:  Rujipat Wasitthankasem; Nawarat Posuwan; Preeyaporn Vichaiwattana; Apiradee Theamboonlers; Sirapa Klinfueng; Viboonsak Vuthitanachot; Napha Thanetkongtong; Siriporn Saelao; Monthana Foonoi; Apinya Fakthongyoo; Jamorn Makaroon; Klaita Srisingh; Duangporn Asawarachun; Somchai Owatanapanich; Norra Wutthiratkowit; Kraisorn Tohtubtiang; Pornsak Yoocharoen; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

9.  Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea.

Authors:  Do Young Kim; Kwang-Hyub Han; Byungyool Jun; Tae Hyun Kim; Sohee Park; Thomas Ward; Samantha Webster; Phil McEwan
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

10.  Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India.

Authors:  Yashika Chugh; Radha Krishan Dhiman; Madhumita Premkumar; Shankar Prinja; Gagandeep Singh Grover; Pankaj Bahuguna
Journal:  PLoS One       Date:  2019-08-29       Impact factor: 3.240
View more
  5 in total

Review 1.  Overview of Complications in Cirrhosis.

Authors:  Madhumita Premkumar; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2022-05-14

2.  Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study.

Authors:  Hsu-Heng Yen; Pei-Yuan Su; I-L Ing Liu; Ya-Huei Zeng; Siou-Ping Huang; Yu-Chun Hsu; Po-Ke Hsu; Yang-Yuan Chen
Journal:  BMC Gastroenterol       Date:  2021-05-08       Impact factor: 3.067

Review 3.  Should We Treat Immune Tolerant Chronic Hepatitis B? Lessons from Asia.

Authors:  Madhumita Premkumar; Yogesh K Chawla
Journal:  J Clin Exp Hepatol       Date:  2021-08-27

4.  Outcomes of Real-World Integrated HCV Microelimination for People Who Inject Drugs: An expansion of the Punjab Model.

Authors:  Radha K Dhiman; Gagandeep S Grover; Madhumita Premkumar; Akash Roy; Sunil Taneja; Ajay Duseja; Sanjeev Arora
Journal:  EClinicalMedicine       Date:  2021-10-17

5.  Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study.

Authors:  Chen-Hua Liu; Hsin-Yun Sun; Cheng-Yuan Peng; Szu-Min Hsieh; Sheng-Shun Yang; Wei-Yu Kao; Yu-Lueng Shih; Chih-Lin Lin; Chun-Jen Liu; Wang-Hui Sheng; Yi-Chun Lo; Wen-Chun Liu; Jo-Hsuan Wu; Tung-Hung Su; Tai-Chung Tseng; Pei-Jer Chen; Chien-Ching Hung; Jia-Horng Kao
Journal:  Open Forum Infect Dis       Date:  2022-07-22       Impact factor: 4.423
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.